Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Pharmacogenomics of biological treatment in rheumatoid arthritis.

Expert opinion on biological therapy - 1 Feb 2014

Xie Xi, Zhang David, Chen Jin-wei, Tian Jing, Ling Guang-hui, Li Fen

Abstract excerpt

INTRODUCTION: Rheumatoid arthritis (RA) demonstrates a high heterogeneity in clinical responses to treatment. Although the efficacy of biological therapy has undoubtedly been established, the response differs considerably between individuals. This variability between individuals has aroused the research for biomarkers predictive of treatment response. Pharmacogenomics underlying individual responses to drugs is...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antibodies, Monoclonal, Murine-Derived
Share to Antigens, CD20

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Biological Products

Share to Etanercept

Share to Infliximab

Share to Receptors, Interleukin-6

Share to Receptors, Tumor Necrosis Factor

Share to Rituximab

Source

Identifiers

PMID: 24295560
DOI: 10.1517/14712598.2014.859672

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Pharmacogenomics of biological treatment in rheumatoid arthritis.PMID 24295560Read ↗

Pharmacogenomics in rheumatoid arthritis.Semantic proximity Read ↗

-Omic Approaches and Treatment Response in Rheumatoid ArthritisSemantic proximity Read ↗

Polymorphisms Involved in Response to Biological Agents Used in Rheumatoid Arthritis.Semantic proximity Read ↗

Pharmacogenetics of disease-modifying antirheumatic drugs in rheumatoid arthritis: towards personalized medicine.Semantic proximity Read ↗

Pharmacogenetics of therapies in rheumatoid arthritis: An update.Semantic proximity Read ↗

Personalized medicine in rheumatoid arthritis: hopes and challenges.Semantic proximity Read ↗

Biomarkers to Personalize the Treatment of Rheumatoid Arthritis: Focus on Autoantibodies and PharmacogeneticsSemantic proximity Read ↗

Pharmacogenomics of Anti-TNF Treatment Response Marks a New Era of Tailored Rheumatoid Arthritis Therapy.Semantic proximity Read ↗

Multi-omics monitoring of drug response in rheumatoid arthritis in pursuit of molecular remissionSemantic proximity Read ↗

Pharmacogenetics in treatment of rheumatoid arthritis.Semantic proximity Read ↗

Precision medicine and management of rheumatoid arthritis.Semantic proximity Read ↗

Can rheumatoid arthritis responsiveness to methotrexate and biologics be predicted?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.